Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.

Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.

Item
http://www.wikidata.org/entity/Q34205047
Pancreatic carboxyl ester lipase: a circulating enzyme that modifies normal and oxidized lipoproteins in vitroImpaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages.Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrixLipoprotein lipase: recent contributions from molecular biology.How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotesPresecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality controlPractical guidelines for familial combined hyperlipidemia diagnosis: an up-date.The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism.Myristic acid increases dense lipoprotein secretion by inhibiting apoB degradation and triglyceride recruitment.Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants.Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity.
P2860

Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.

Item
http://www.wikidata.org/entity/Q34205047
description
1991 nî lūn-bûn
@nan
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@ast
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@en
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@nl
type
label
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@ast
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@en
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@nl
prefLabel
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@ast
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@en
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Lipoprotein lipase modulates n ...... ilial combined hyperlipidemia.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932